Insulet Corp
PODD325.840USD
+1.089+0.34%
종가 05/19, 16:00（ET）시세는 15분 지연됩니다
22.93B시가총액
54.81P/E TTM
자세한 내용은 Insulet Corp 회사
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
회사 정보
회사 코드PODD
회사 이름Insulet Corp
상장일May 15, 2007
설립일2000
CEOMs. Ashley Mcevoy
직원 수3900
유형Ordinary Share
회계 연도 종료May 15
주소100 Nagog Park
도시ACTON
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호01720-3440
전화19786007000
웹사이트https://www.omnipod.com
회사 코드PODD
상장일May 15, 2007
설립일2000
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
26.92K
--
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
15.45K
+5.77%
Mr. Eric Benjamin
Mr. Eric Benjamin
Executive Vice President, Chief Product and Customer Experience Officer
Executive Vice President, Chief Product and Customer Experience Officer
14.73K
--
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238.50K%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
5.32K
+50.42%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
4.46K
--
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.58K
+24.38%
Ms. Ana Maria Chadwick
Ms. Ana Maria Chadwick
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
2.88K
-38.03%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
2.79K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
26.92K
--
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
15.45K
+5.77%
Mr. Eric Benjamin
Mr. Eric Benjamin
Executive Vice President, Chief Product and Customer Experience Officer
Executive Vice President, Chief Product and Customer Experience Officer
14.73K
--
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238.50K%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
5.32K
+50.42%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
사업별USD
이름
수익
비율
U.S.Omnipod
1.51B
72.86%
International Omnipod
523.40M
25.27%
Drug Delivery
38.90M
1.88%
지역별USD
이름
수익
비율
United States
1.55B
74.73%
All Other
523.40M
25.27%
사업별
지역별
사업별USD
이름
수익
비율
U.S.Omnipod
1.51B
72.86%
International Omnipod
523.40M
25.27%
Drug Delivery
38.90M
1.88%
주주
업데이트 시간: Fri, May 16
업데이트 시간: Fri, May 16
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
12.27%
Fidelity Management & Research Company LLC
10.13%
Capital Research Global Investors
8.63%
BlackRock Institutional Trust Company, N.A.
6.20%
State Street Global Advisors (US)
4.30%
Other
58.47%
주주 통계
주주
비율
The Vanguard Group, Inc.
12.27%
Fidelity Management & Research Company LLC
10.13%
Capital Research Global Investors
8.63%
BlackRock Institutional Trust Company, N.A.
6.20%
State Street Global Advisors (US)
4.30%
Other
58.47%
유형
주주
비율
Investment Advisor
55.81%
Investment Advisor/Hedge Fund
35.99%
Hedge Fund
3.40%
Research Firm
2.90%
Pension Fund
1.66%
Sovereign Wealth Fund
1.43%
Bank and Trust
1.38%
Individual Investor
0.29%
Private Equity
0.10%
기관 주식 보유
업데이트 시간: Mon, Jan 20
업데이트 시간: Mon, Jan 20
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
1519
73.36M
104.26%
-4.82M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
2023Q2
1223
73.42M
105.35%
-3.44M
2023Q1
1206
74.71M
107.20%
-300.49K
2022Q4
1126
71.74M
103.30%
-3.89M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
8.46M
12.05%
+16.65K
+0.20%
Dec 31, 2024
Fidelity Management & Research Company LLC
7.08M
10.08%
-246.09K
-3.36%
Dec 31, 2024
Capital Research Global Investors
7.45M
10.6%
-326.10K
-4.20%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.25M
6.05%
+74.08K
+1.77%
Dec 31, 2024
State Street Global Advisors (US)
2.97M
4.24%
+59.55K
+2.04%
Dec 31, 2024
Baillie Gifford & Co.
2.36M
3.35%
+79.98K
+3.51%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.78M
2.53%
+40.57K
+2.33%
Dec 31, 2024
ClearBridge Investments, LLC
1.41M
2%
-62.73K
-4.27%
Dec 31, 2024
Fidelity International
1.43M
2.04%
-9.70K
-0.67%
Dec 31, 2024
American Century Investment Management, Inc.
854.87K
1.22%
-3.60K
-0.42%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
Langar Global HealthTech ETF
5.12%
Goldman Sachs Future Health Care Equity ETF
4.54%
Global X Telemedicine & Digital Health ETF
4.21%
Fidelity Digital Health ETF
3.91%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.84%
FT Raymond James Multicap Growth Equity ETF
2.7%
Congress SMid Growth ETF
2.66%
Nuveen ESG Mid-Cap Growth ETF
2.13%
iShares U.S. Medical Devices ETF
2.03%
Harbor Health Care ETF
2.02%
더 보기
Langar Global HealthTech ETF
비율5.12%
Goldman Sachs Future Health Care Equity ETF
비율4.54%
Global X Telemedicine & Digital Health ETF
비율4.21%
Fidelity Digital Health ETF
비율3.91%
First Trust Nasdaq Lux Digi Health Solutions ETF
비율3.84%
FT Raymond James Multicap Growth Equity ETF
비율2.7%
Congress SMid Growth ETF
비율2.66%
Nuveen ESG Mid-Cap Growth ETF
비율2.13%
iShares U.S. Medical Devices ETF
비율2.03%
Harbor Health Care ETF
비율2.02%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
